These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21076988)

  • 1. Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation.
    Korchounov A; Meyer MF; Krasnianski M
    J Neural Transm (Vienna); 2010 Dec; 117(12):1359-69. PubMed ID: 21076988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α4 nicotinic acetylcholine receptor modulated by galantamine on nigrostriatal terminals regulates dopamine receptor-mediated rotational behavior.
    Inden M; Takata K; Yanagisawa D; Ashihara E; Tooyama I; Shimohama S; Kitamura Y
    Neurochem Int; 2016 Mar; 94():74-81. PubMed ID: 26911419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic and dopaminergic modulation of potassium conductances in neostriatal neurons.
    Kitai ST; Surmeier DJ
    Adv Neurol; 1993; 60():40-52. PubMed ID: 8380527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT; Wachtel SR; Galloway MP; White FJ
    J Neurosci; 1990 Jul; 10(7):2318-29. PubMed ID: 1973947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
    Jung AB; Bennett JP
    Brain Res Dev Brain Res; 1996 Jul; 94(2):109-20. PubMed ID: 8836569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone.
    Double KL; Crocker AD
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1669-73. PubMed ID: 7878037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine depletion on rotational behavior to dopamine agonists.
    Gershanik O; Heikkila RE; Duvoisin RC
    Brain Res; 1983 Feb; 261(2):358-60. PubMed ID: 6831221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra.
    Crocker AD
    Rev Neurosci; 1997; 8(1):55-76. PubMed ID: 9402645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways.
    Nylander I; Terenius LH
    Neuropharmacology; 1987 Sep; 26(9):1295-302. PubMed ID: 2444900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
    Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons.
    Beckstead RM
    Neuroscience; 1988 Dec; 27(3):851-63. PubMed ID: 3150855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The model of dopaminergic regulation of involuntary movements].
    Korshunov AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(8):87-9. PubMed ID: 19130671
    [No Abstract]   [Full Text] [Related]  

  • 20. Restoration of nigrostriatal synaptic circuitry, striatal mRNA expression, and motor symmetry following embryonic substantia nigra grafts.
    Mendez I; Elisevich K; Naus C; Flumerfelt B
    Clin Neurosurg; 1992; 38():180-209. PubMed ID: 1371434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.